Acorda Therapeutics | ACOR - Activos Circulantes



Activos Circulantes Cambio Fecha
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
ALKERMES USD 1.52B 164.26M 2026-06
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Amgen USD 34.96B 3.49B 2026-06
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
Biogen USD 7.31B 1.88B 2026-06
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Cara Therapeutics USD 25.33M 6.21M 2026-03
Cipla INR 241.47B 7.71B 2026-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 137.28M 10.74M 2026-03
CSL USD 11.85B 1000K 2025-12
Cytokinetics USD 1.21B 369.02M 2026-06
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Gilead Sciences USD 12.53B 6.11B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
Grifols EUR 5.96B 316.31M 2025-12
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Heron Therapeutics USD 229.84M 861K 2026-06
Insmed USD 1.63B 20.75M 2026-06
Ligand Pharmaceuticals USD 1.46B 591.7M 2026-06
MannKind USD 245.71M 5.45M 2026-06
Merck EUR 13.77B 393M 2026-06
Moderna USD 5.82B 45M 2026-06
Neurocrine Biosciences USD 1.64B 798.6M 2026-06
Novartis USD 27.35B 744M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06